
Amplify Care Unveils New Brand Identity, Leading the Way in Connecting Primary Care with Digital Health and AI Innovations
KITCHENER, ON , May 28, 2025 /CNW/ - Amplify Care, formerly known as the eHealth Centre of Excellence, is excited to unveil our new brand identity – a reflection of our deepened commitment to being the bridge between technology and primary care clinicians across Canada . As primary care faces unprecedented challenges, including a severe family doctor shortage amidst growing administrative burdens, Amplify Care has made it our mission to advocate for clinicians by amplifying their voices and supporting the adoption of digital health solutions that reduce workload, improve workflows, and empower clinicians to focus on patient care.
In Ontario alone, family physicians are reporting spending up to 19 hours per week on administrative tasks, time that could be spent delivering care. Amplify Care is a not-for-profit organization deeply rooted in a change management ethos, helping clinicians adopt and integrate digital health and AI-powered tools from leading vendors and ensuring these solutions are designed with clinician needs and safety at the forefront. Amplify Care's work is critical in helping primary care clinicians navigate this new era of digital health while maintaining their focus on patient care, not paperwork.
"We're in a healthcare crisis – primary care is overwhelmed, and clinicians are burned out," says Dr. Mohamed Alarakhia , Founder and Chief Executive Officer of Amplify Care. "Our role is to connect the right digital health solutions with primary care practices and ensure that these tools are implemented in ways that meet the real-world needs of clinicians. By advocating for clinicians and amplifying their voices, we ensure that these technologies are practical, effective, and truly reduce the burden on the front lines of healthcare."
Since its inception in 2014, Amplify Care has reached over 17,000 clinicians across Canada and supported more than 60 digital health initiatives, including co-leading the Ontario eServices Program (deploying eReferral and eConsult) and Evidence2Practice Ontario (EMR-integrated decision support tools for primary care). Our new brand identity signals a renewed focus on supporting the digital transformation of primary care through tailored adoption support and advocating for clinician-driven solutions. Amplify Care is not just about implementing technology – it's about ensuring that innovation serves those who matter most: clinicians and their patients.
Connecting Clinicians with the Right Tools: What's Next for Primary Care
Amplify Care partners with clinicians, patients, government agencies, healthcare organizations, and digital health technology providers to integrate innovative digital health tools into primary care settings. Positioned at the forefront of the rapidly evolving healthcare landscape, we help clinicians navigate the complexity of new technologies, cutting through the noise to deliver practical, impactful solutions that improve care delivery and reduce clinician burden. We're currently assessing a few recent innovations that have the potential to change the game for primary care, including: AI Scribes : Automating documentation to save clinicians hours of work each week, freeing up more time for patient interaction.
: Automating documentation to save clinicians hours of work each week, freeing up more time for patient interaction. AI Triage : Helping to prioritize patient care more effectively by leveraging AI to streamline triage and appointment management.
: Helping to prioritize patient care more effectively by leveraging AI to streamline triage and appointment management. AI Inbox Management: Reducing the administrative burden of managing patient communications, prescriptions, and follow-ups through AI-powered inbox solutions.
Amplify Care Drives Meaningful Change and Lasting Impact
Clinician-Led Co-Design: Amplify Care is fueled by clinician perspectives to ensure tools meet their real-world needs and fit seamlessly into existing workflows.
Change Management & Practice Facilitation: We offer comprehensive support to ensure the meaningful adoption of digital tools, empowering clinicians to integrate digital health and AI technologies with confidence and ease.
Evidence-Based Innovation: With over 135 case studies and published evidence briefs, Amplify Care demonstrates the real-world impact of its approach, showing how digital tools can reduce clinician burnout, enhance care delivery, and improve patient outcomes.
"Amplify Care stands out because we truly understand the challenges clinicians face. We don't just implement technology for the sake of it; we ensure that it actually supports clinicians in their work. We're advocates for their needs, amplifying their voices in every conversation with technology vendors, and ensuring that the tools we help bring into their practices truly help them deliver better care with less stress."
- Dr. Mohamed Alarakhia Chief Executive Officer
Amplify Care
"With Amplify Care's support, we were able to adopt an AI scribe that saved us hours each week. They helped us integrate the tool in a way that made sense for our workflow, and the result is less paperwork and more time with patients."
- Dr. Neil Naik Family Physician
Boardwalk Family Care
Learn more about why we're Canada's leading digital health partner – visit our new website here: www.amplifycare.com.
View a video about Amplify Care's rebranding efforts here.
Media contact:
Hannele Kivinen
[email protected]
(226) 343 6995
SOURCE Amplify Care
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
3 hours ago
- Cision Canada
New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure Français
Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20, 2025 /CNW/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures at the ISAPS Olympiad World Congress in Singapore, showing more than 17.4 million procedures performed by plastic surgeons and 20.5 non-surgical procedures. Over the last four years, the overall increase is 42.5%. Aesthetic Procedures Eyelid surgery, for the first time, was the most common surgical procedure in 2024, replacing liposuction, with 2.1 million, followed by liposuction, breast augmentation, scar revision, and rhinoplasty. The most popular non-surgical procedures were botulinum toxin, hyaluronic acid (filler), hair removal, non-surgical skin tightening, and chemical peels. Most face and head procedures showed growth from the previous year, with more than 7.4 million procedures and a 4.3% increase. Top procedures were eyelid surgery with more than 2.1 million and a 13.4% increase, rhinoplasty with 1 million procedures and a 10% decrease, and fat grafting – face 0.9 million and a 19.2% increase. There were 3.9 million breast procedures (-14.1%) and 6 million body and extremities procedures (-14.8%). Liposuction was still the most common surgical procedure for women, followed by eyelid surgery and breast augmentation. Eyelid surgery was again the most popular surgical procedure among men, followed by gynecomastia and scar revision. Most breast augmentations (54% of the total), rhinoplasties (60.1%), and external genital surgery (48.4%) took place on 18–34-year-olds, whereas botulinum toxin injectables were most popular among those aged 35–50 (47.0% of the total). Liposuction and non-surgical fat reduction were distributed quite evenly among both age groups. Botulinum toxin remained the most common non-surgical procedure for both men and women and among all age groups, with 7.8 million procedures performed by plastic surgeons worldwide. In second place, hyaluronic acid procedures increased by 5.2% to 7.8 million. Commenting on the global results, Dr. Amin Kalaaji, Chair of the ISAPS Global Survey Committee and plastic surgeon in Norway, said, "Our report now includes data on 'Mommy Makeover' and other combined procedures, scar revision, hand rejuvenation with fat grafting, buccal fat removal, inverted nipple correction, dimple creation, and other outer genital surgery." Once again, the US performed the most procedures with over 6.1 million, followed by Brazil with 3.1 million (which is first in surgical procedures), and Japan. For media inquiries, please contact [email protected].


Cision Canada
11 hours ago
- Cision Canada
THE FIRST NATIONS HEALTH MANAGERS ASSOCIATION TO LEAD MULTI-YEAR INDIGENOUS HEALTH NAVIGATORS (IHN) TRAINING AND CURRICULUM DEVELOPMENT INITIATIVE
OTTAWA, ON, /CNW/ - The First Nations Health Managers Association (FNHMA) is leading a multi-year project focused on developing a comprehensive training and curriculum program for Indigenous Health Navigators (IHN). IHNs have been recognized as essential roles within the Indigenous health system workforce. These professionals possess a deep understanding of the complex jurisdictional health landscape and the historical and current realities faced by First Nations patients and families. IHNs provide culturally safe and trauma-informed support, acting as vital bridges between community-based health services and the mainstream health systems often accessed in urban settings. Through this initiative, FNHMA will support the development of a national network by identifying and establishing standardized competencies that reflect the diverse skill set of the current workforce. These competencies are intended to complement the work of First Nations Health Managers and strengthen the overall health management framework within First Nations communities. Building on previous foundational work, the project will assess the existing landscape of the IHN role, propose a vision for its future evolution, and identify best practices and accredited training opportunities. Additionally, the initiative will focus on the development of core competencies, curriculum, and instructional materials, while delivering an actionable implementation plan to meet workforce needs and enhance career pathways for IHN. This initiative reflects FNHMA's ongoing commitment to capacity building and the advancement of Indigenous-led health services. As always, FNHMA's approach is grounded in engagement with its' members and partners whose knowledge and lived experience is instrumental in guiding the project's direction. FNHMA is pleased to announce that Dr. Pamela Toulouse has been appointed as the Lead Consultant for this initiative. Dr. Toulouse is a respected educator, researcher, and advocate with extensive experience in Indigenous health, education, and community empowerment.


Cision Canada
18 hours ago
- Cision Canada
Approved by Health Canada - Zilia Ocular: A World First Set to Revolutionize Eye Care
QUEBEC CITY, June 19, 2025 /CNW/ - Zilia, a Canadian health technology company, is proud to announce that its flagship product, the Zilia Ocular™, has received approval from Health Canada. It is the first device in the world authorized to measure oxygen saturation in the eye—a breakthrough that has the potential to redefine eye care. Developed in Quebec City, the Zilia Ocular is a revolutionary retinal camera equipped with a patented optical technology that enables the non-invasive measurement of oxygenation in the eye. This metabolic biomarker gives eye care professionals an entirely new window into the physiological state of the eye, with the goal of detecting issues well before structural damage occurs. "This represents a true paradigm shift," said Dr. Patrick Sauvageau, optometrist, CEO and co-founder of Zilia. "By measuring retinal oxygenation in real time, we aim to help clinicians detect and manage eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration more effectively." A Breakthrough at the Heart of Oculomics As oculomics—an emerging field that uses the eye as a gateway to assess overall health—gains traction globally, biomarkers like oxygen saturation are paving the way for a more preventive, personalized, and data-driven approach to medicine. The Zilia Ocular is at the forefront of this movement, introducing a layer of analysis that was previously inaccessible in clinical settings. Zilia plans to launch its device in Canada in the coming months, followed by expansion into the United States and Europe. About Zilia Zilia is a health technology company developing a groundbreaking platform to non-invasively measure biomarkers in the eye, with an initial focus on ocular oximetry. By integrating advanced photonics and artificial intelligence, Zilia's first-of-kind technology is intended to leverage the eye's optical properties and direct connections to the vascular system and the brain to capture critical information on ocular and overall health.